The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AEROVATE THERAPEUTICS INC COMM 008064107   29,871,288 2,201,274 SH   SOLE   2,201,274 0 0
AN2 Therapeutics, Inc. COMM 037326105   43,065,600 2,678,209 SH   SOLE   2,678,209 0 0
C4 THERAPEUTICS, INC. COMM 12529R107   2,374,427 1,276,574 SH   SOLE   1,276,574 0 0
CABALETTA BIO, INC COMM 12674W109   7,409,020 486,795 SH   SOLE   486,795 0 0
CENTESSA PHARMACEUTICALS PLC COMM 152309100   13,204,079 2,040,816 SH   SOLE   2,040,816 0 0
COGENT BIOSCIENCES INC COMM 19240Q201   54,902,659 5,631,042 SH   SOLE   5,631,042 0 0
COMPASS PATHWAYS PLC ADRS 20451W101   28,549,200 3,858,000 SH   SOLE   3,858,000 0 0
DYNE THERAPEUTICS, INC COMM 26818M108   14,785,344 1,650,150 SH   SOLE   1,650,150 0 0
ENTRADA THERAPEUTICS INC COMM 29384C108   9,242,289 584,955 SH   SOLE   584,955 0 0
GERON CORP COMM 374163103   49,556,779 23,375,839 SH   SOLE   23,375,839 0 0
GRACELL BIOTECHNOLOGIES INC. ADRS 38406L103   8,752,000 3,038,889 SH   SOLE   3,038,889 0 0
Icosavax, Inc. COMM 45114M109   28,703,706 3,703,704 SH   SOLE   3,703,704 0 0
IMMUNOVANT, INC COMM 45258J102   12,855,006 334,853 SH   SOLE   334,853 0 0
INHIBRX,INC COMM 45720L107   32,119,601 1,750,387 SH   SOLE   1,750,387 0 0
KALVISTA PHARMACEUTICALS, INC COMM 483497103   32,698,617 3,395,495 SH   SOLE   3,395,495 0 0
KURA ONCOLOGY INC COMM 50127T109   12,983,615 1,423,642 SH   SOLE   1,423,642 0 0
MADRIGAL PHARMACEUTICALS INC COMM 558868105   26,275,079 179,917 SH   SOLE   179,917 0 0
MERUS N.V. COMM N5749R100   7,074,000 300,000 SH   SOLE   300,000 0 0
SAVARA INC. COMM 805111101   37,800,000 10,000,000 SH   SOLE   10,000,000 0 0
SILENCE THERAPEUTICS PLC ADRS 82686Q101   20,669,873 2,104,875 SH   SOLE   2,104,875 0 0
TARSUS PHARMACEUTICALS, INC. COMM 87650L103   20,308,569 1,142,857 SH   SOLE   1,142,857 0 0
TAYSHA GENE THERAPIES, INC. COMM 877619106   35,111,111 11,111,111 SH   SOLE   11,111,111 0 0
TYRA BIOSCIENCES INC COMM 90240B106   27,389,948 1,989,103 SH   SOLE   1,989,103 0 0
VENTYX BIOSCIENCES, INC COMM 92332V107   28,330,095 815,724 SH   SOLE   815,724 0 0
STRUCTURE THERAPEUTICS INC ADRS 86366E106   75,768,504 1,502,747 SH   SOLE   1,502,747 0 0
RAYZEBIO, INC. COMM 75525N107   19,311,958 869,908 SH   SOLE   869,908 0 0